About Dipanjan Banchur
Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets. His goal is to help investors make the best investment decisions based on a fundamental approach.
Recent Articles By Dipanjan Banchur
Salesforce.com Inc (CRM): An Assessment of This Software Stock
Enterprise software giant Salesforce (CRM) raised prices across its software offerings for the first time in seven years to boost its revenues. The company also revealed its new AI products at its Dreamforce conference. Additionally, it surprised the Street with its optimistic guidance for fiscal 2024. Given this backdrop, would investing in the stock now be wise? Read on…
3 Top-Rated Stock Buys in the Consumer Financial Sector
Financial companies are well-positioned to benefit, with the Fed likely to keep the interest rates elevated for longer than expected. Therefore, it could be wise to buy fundamentally strong consumer financial stocks OneMain Holdings (OMF), FirstCash Holdings (FCFS), and Regional Management (RM). Read more…
Should You Pool Your Money Into Apple (AAPL) Stock This Week?
Investors have been tracking tech giant Apple (AAPL) closely as it is due to launch its much-awaited new iPhone and Apple watch later today. However, the recent ban by China on the use of AAPL products by employees working at the central and state governments and state-owned companies will likely keep investors worried, as China is a crucial market for the company. Should you pool your money into AAPL stock this week amid this uncertainty? Read on…
Bank of America (BAC) vs. Wells Fargo (WFC) vs. JPMorgan (JPM): Which Bank Stock Has Better Momentum Behind It?
The U.S. banking industry currently faces challenges like rising deposit costs, rating downgrades, slowing loan growth, stricter lending standards, etc. Therefore, watching the momentum of major banks like JPMorgan Chase (JPM), Wells Fargo (WFC), and Bank of America (BAC) could offer investment opportunities. Let’s find out which of these stocks can survive the challenges and deliver attractive returns...
3 Software Investments Better Than Robinhood (HOOD)
The ever-rising use of business software applications is boosting the prospects of the software application industry. Additionally, integrating generative AI into these applications will likely boost the industry’s prospects. Considering these factors, investors could buy quality software stocks Adobe (ADBE), Salesforce (CRM), and eGain (EGAN) instead of fundamentally weak Robinhood Markets (HOOD). Read more…
3 Grocery Stocks to Watch This Fall
Interest rates, resumption of student debt repayments, falling savings, and several other macro factors are expected to pressure consumer spending in the near-to-mid term. Therefore, it could be wise to add grocery stocks Tesco (TSCDY), Target (TGT), and Costco (COST) to one’s watchlist, as an inelastic demand can help these companies survive the lackluster spending environment well. Read on…
JPMorgan Chase & Co. (JPM): September Buy, Sell or Hold?
The banking industry is facing another crisis as top credit rating agencies have downgraded several banks and warned of potential downgrades for America’s largest lenders. Amid this uncertainty, let’s find out if buying, selling, or holding JPMorgan Chase (JPM) would be wise...
Top "A" Rated Auto Stocks to Buy This Week
Easing inflation, strong demand, and the recovery in the supply chain are some of the factors boosting the prospects of the auto industry. Amid this backdrop, it could be wise to buy fundamentally strong auto stocks Rolls-Royce Holdings (RYCEY), Stellantis (STLA), and Honda Motor (HMC). Our proprietary rating system rates These stocks “A” (Strong Buy). Read on…
3 Pharma Stocks for Value Investors
The aging global population and the growing demand for drugs and therapies to treat chronic diseases are boosting the long-term prospects of the pharmaceutical industry. Amid this backdrop, value investors could consider buying fundamentally strong pharma stocks GSK plc (GSK), Horizon Therapeutics (HZNP), and Neurocrine Biosciences (NBIX), as they are currently trading at discounts to their peers. Read on…